Found 69 matching trials
Flortaucipir PET Imaging in the Preclinical, Prodromal and Dementia Phases of Alzheimer's Disease
PHASE1A Phase 1 study designed to evaluate imaging characteristics of flortaucipi...
Location
Multiple Locations
Tau Tracer Comparison in Healthy Controls and Alzheimer's Disease Patients
NAThe primary objective of this study is to identify a new radioligand for im...
Location
John Hopkins Hospital
F 18 T807 Tau PET Imaging of Progressive Posterior Cortical Dysfunction (IND 123119, Protocol E)
N/AThis project will collect quantitative pilot data that will allow the chara...
Location
Washington University School of Medicine
Tau Screening Study in Patients With Early Symptomatic AD
PHASE2This protocol is designed to serve as a pre-screening study for subjects wh...
Location
Pacific Research Network
Exploratory Evaluation of Flortaucipir Injection in Healthy Volunteers and Cognitively Impaired Subjects
EARLY_PHASE1This early phase 1 study explored the brain uptake, retention, and safety o...
A Direct Comparative Study of Tau Tracer in Patients With Alzheimer's Disease
N/AIn this study, a total of 60 AD patients with Aฮฒ deposition will beenrolled...
Augmenting Flortaucipir Dosimetry Estimates
PHASE1This study will obtain data from urine in subjects administered flortaucipi...
Location
Molecular NeuroImaging
18F-AV-1451 and Florbetapir F 18 PET (Positron Emission Tomography) Imaging in Subjects at Risk for Chronic Traumatic Encephalopathy
PHASE2This study will explore the use of flortaucipir as a biomarker for chronic ...
Location
Banner Alzheimer's Institute
Tau Pet Imaging in the Aging Brain Cohort Dedicated to Diversity Study
N/AWe will conduct a Tau PET scan in cognitively normal older adults, enrolled...
Status
Active Not Recruiting
Location
Hospital of the University of Pennsylvania - Penn Memory Center
Imaging Characteristics of a Follow-up 18F-AV-1451 Scan
PHASE2This study will evaluate the imaging characteristics of flortaucipir in sub...
Location
Hoag Memorial Hospital